• BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Receives Consensus Rating of "Moderate Buy" from Brokerages

    Source: Buzz FX / 04 Dec 2024 03:36:12   America/New_York


    BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Receives Consensus Rating of "Moderate Buy" from Brokerages Written by MarketBeat December 4, 2024 Share Link copied to clipboard. Shares of BioCryst Pharmaceuticals, Inc.
    Read more...
Share on,